These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 9767516)
1. Pneumocystis carinii pneumonia: pitfalls of prophylaxis. Massie RJ; Cooper PJ; Van Asperen PP; McIntyre P J Paediatr Child Health; 1998 Oct; 34(5):477-9. PubMed ID: 9767516 [TBL] [Abstract][Full Text] [Related]
2. Failure of trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis carinii pneumonia with concurrent leucovorin use. Razavi B; Lund B; Allen BL; Schlesinger L Infection; 2002 Jan; 30(1):41-2. PubMed ID: 11876516 [TBL] [Abstract][Full Text] [Related]
3. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Green H; Paul M; Vidal L; Leibovici L Cochrane Database Syst Rev; 2007 Jul; (3):CD005590. PubMed ID: 17636808 [TBL] [Abstract][Full Text] [Related]
4. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole. Fisher RG; Nageswaran S; Valentine ME; McKinney RE AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767 [TBL] [Abstract][Full Text] [Related]
5. Altered trimethoprim-sulfamethoxazole ratios for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii dual infections in rat model. Brun-Pascaud M; Chau F; Garry L; Farinotti R; Derouin F; Girard PM J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):201-7. PubMed ID: 8898664 [TBL] [Abstract][Full Text] [Related]
6. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Stern A; Green H; Paul M; Vidal L; Leibovici L Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005590. PubMed ID: 25269391 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Pneumocystis carinii pneumonia in patients with AIDS. Wordell CJ; Hauptman SP Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063 [TBL] [Abstract][Full Text] [Related]
8. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases. Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257 [TBL] [Abstract][Full Text] [Related]
9. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544 [TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Green H; Paul M; Vidal L; Leibovici L Mayo Clin Proc; 2007 Sep; 82(9):1052-9. PubMed ID: 17803871 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic failure of trimethoprim/sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. al-Tawfiq JA; Sorensen SJ; Cushing HE Ann Pharmacother; 1999 Apr; 33(4):413-5. PubMed ID: 10332530 [TBL] [Abstract][Full Text] [Related]
12. Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population. McLaughlin MM; Galal A; Richardson CL; Sutton SH; Barr VO; Patel N; Mitchell P; Stosor V Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28833985 [TBL] [Abstract][Full Text] [Related]
13. Preventive effect of sulfamethoxasole-trimethoprim on Pneumocystis jiroveci pneumonia in patients with interstitial pneumonia. Enomoto T; Azuma A; Matsumoto A; Nei T; Fujita K; Hattori K; Saito Y; Abe S; Usuki J; Kudoh S Intern Med; 2008; 47(1):15-20. PubMed ID: 18175999 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study. Yamashita K; Shimomura Y; Ikesue H; Muroi N; Yoshimoto A; Hashida T BMC Infect Dis; 2021 Jul; 21(1):664. PubMed ID: 34238239 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation. Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458 [TBL] [Abstract][Full Text] [Related]
17. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. Kazanjian P; Locke AB; Hossler PA; Lane BR; Bartlett MS; Smith JW; Cannon M; Meshnick SR AIDS; 1998 May; 12(8):873-8. PubMed ID: 9631140 [TBL] [Abstract][Full Text] [Related]
18. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia. Madhi SA; Cutland C; Ismail K; O'Reilly C; Mancha A; Klugman KP Clin Infect Dis; 2002 Nov; 35(9):1120-6. PubMed ID: 12384847 [TBL] [Abstract][Full Text] [Related]
19. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. Carr A; Tindall B; Penny R; Cooper DA AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714 [TBL] [Abstract][Full Text] [Related]
20. Pneumocystis jirovecii pneumonia in kidney transplantation. Goto N; Oka S Transpl Infect Dis; 2011 Dec; 13(6):551-8. PubMed ID: 22093172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]